Combination approaches and anti-PD1 therapies: the focus of new research at ESMO and SMR
{{output}}
Research into the treatment of melanoma is continuing to progress, and both the European Society of Medical Oncology (26-30 September, Madrid, Spain) and the Society of Melanoma Research (13-16 November, Zurich, Switzerland) 2014 annual meetings provided impor... ...
